ARTICLE | Clinical News
Civamide Patch: Preliminary Phase II data
November 23, 2009 8:00 AM UTC
Top-line data from the open-label Phase II WL1001-04-03 trial in 20 patients with chronic, intractable PHN unresponsive or poorly responsive to standard oral therapies showed that 0.015% Civamide Patc...